Sovenyr
Get early access
Signal
2026-08-04
ClinicalTrials.gov
[PHASE2] Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
Part of
Advancing Psychedelic And Novel Therapeutics
Open primary source
See the whole picture